Showing 17,881 - 17,900 results of 29,662 for search '(( 50 ((na decrease) OR (((mean decrease) OR (a decrease)))) ) OR ( 12 wt decrease ))', query time: 1.05s Refine Results
  1. 17881
  2. 17882

    Variation of average codeword length (ACL) by number of edges. by Dario Elias (8882177)

    Published 2020
    “…A positive variation indicates a decrease in the ACL. …”
  3. 17883

    Complementary conditioning measures across the clinical study groups. by Gabriela Ribeiro (4748373)

    Published 2024
    “…CS<sup>+</sup> (F<sub>(1, 50)</sub> = 5.2, <i>P</i> = 0.03), with a no significant effects for Group (F<sub>(2, 50)</sub> = 0.1, <i>P</i> = 0.9) nor for interaction (F<sub>(2, 50)</sub> = 0.9, <i>P</i> = 0.4). …”
  4. 17884
  5. 17885
  6. 17886

    Homogalacturonan epitopes in wheat mature grain: effect of different treatments on LM20 labeling. by Anne-Laure Chateigner-Boutin (508214)

    Published 2014
    “…Bars represent 250 µm for A, 50 µm for I (the same scale was applied for B, C, D, E, F, G and H).…”
  7. 17887
  8. 17888
  9. 17889

    Excitation-Contraction Coupling in Zebrafish Ventricular Myocardium Is Regulated by Trans-Sarcolemmal Ca<sup>2+</sup> Influx and Sarcoplasmic Reticulum Ca<sup>2+</sup> Release by Moritz Haustein (734263)

    Published 2015
    “…Surprisingly though, inhibition of the sarcoplasmic Ca<sup>2+</sup>-release decreased force development to 54±3% in ventricular (n=13, p<0.05) and to 52±8% in atrial myocardium (n=5, p<0.05) suggesting a substantial role of SR Ca<sup>2+</sup>-release in force generation. …”
  10. 17890

    Histone deacetylase (HDAC) inhibitor assessment. by Ilona Tkachyova (343715)

    Published 2016
    “…ITF 2357, an HDAC inhibitor which is structurally and functionally similar to SAHA, produced a dose-response curve with IC<sub>50</sub> of 0.2 μM. …”
  11. 17891

    Plk1 inhibition suppresses the clonogenic potential of SUM149 and SUM159. by Antonio Giordano (55096)

    Published 2019
    “…(B) EC<sub>50</sub> was defined as 50% colony inhibition. Single agents EC<sub>50</sub> were reported for each TNBC cell line and drug. …”
  12. 17892

    Image2_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.jpeg by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”
  13. 17893

    Image1_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.jpeg by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”
  14. 17894

    Table4_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”
  15. 17895

    Image3_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.pdf by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”
  16. 17896

    Table3_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”
  17. 17897

    Image4_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.pdf by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”
  18. 17898

    Table2_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”
  19. 17899

    Accelerated Optical Projection Tomography Applied to <i>In Vivo</i> Imaging of Zebrafish by Teresa Correia (3956129)

    Published 2015
    “…In this work, we demonstrate that the use of an iterative algorithm to reconstruct sparsely sampled OPT data sets can provide useful 3-D images with 50 or fewer projections, thereby significantly decreasing the minimum acquisition time and light dose while maintaining image quality. …”
  20. 17900

    Table 1_Elucidating the effects of nine-steaming-nine-drying on the morphology, metabolomic profile, and active ingredients of Polygonatum sibiricum Redouté.xls by Rui Wang (52434)

    Published 2025
    “…These alterations resulted in darker coloration, as evidenced by a significant decrease in L* values, elimination of tongue-numbing effects, enhanced sweetness, and improved quality of P. sibiricum Red. …”